| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |